These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17548948)

  • 21. Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.
    Hirakawa M; Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H
    Intern Med; 2008; 47(19):1637-43. PubMed ID: 18827409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.
    Toyoda H; Kumada T; Tokuda A; Horiguchi Y; Nakano H; Honda T; Nakano S; Hayashi K; Katano Y; Nakano I; Hayakawa T; Nishimura D; Kato K; Imada K; Imoto M; Fukuda Y;
    J Viral Hepat; 2000 Nov; 7(6):414-9. PubMed ID: 11115052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review.
    Saito M; Seo Y; Yano Y; Miki A; Morinaga Y; Itoh T; Yoshida M; Azuma T
    Clin J Gastroenterol; 2012 Apr; 5(2):119-26. PubMed ID: 26182154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
    Lin A; Kadam JS; Bodenheimer HC; Leonard J; Joyce MA; Lake-Bakaar G
    J Med Virol; 2008 Aug; 80(8):1350-3. PubMed ID: 18551608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.
    Okanoue T; Itoh Y; Minami M; Sakamoto S; Yasui K; Sakamoto M; Nishioji K; Murakami Y; Kashima K
    J Hepatol; 1999 Apr; 30(4):653-9. PubMed ID: 10207807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C.
    Khokhar N; Niazi TK; Qureshi MO
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):699-702. PubMed ID: 24112253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
    Toyoda H; Tada T; Takaguchi K; Senoh T; Shimada N; Hiraoka A; Michitaka K; Ishikawa T; Kumada T
    J Viral Hepat; 2017 Jun; 24(6):472-476. PubMed ID: 27983762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
    Kim GA; Han S; Kim HD; An J; Lim YS
    J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation.
    Zanaga LP; Vigani AG; Angerami RN; Giorgetti A; Escanhoela CA; Ataíde EC; Boin IF; Stucchi RS
    Braz J Med Biol Res; 2017 Jan; 50(1):e5540. PubMed ID: 28076451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of interferon therapy for reducing the incidence of hepatocellular carcinoma among patients with type C chronic hepatitis.
    Inoue A; Tsukuma H; Oshima A; Yabuuchi T; Nakao M; Matsunaga T; Kojima J; Tanaka S
    J Epidemiol; 2000 Jul; 10(4):234-40. PubMed ID: 10959605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?
    Blanco JR; Rivero-Juárez A
    Expert Rev Anti Infect Ther; 2016 Nov; 14(11):993-996. PubMed ID: 27686837
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.
    Kawaguchi T; Ide T; Koga H; Kondo R; Miyajima I; Arinaga-Hino T; Kuwahara R; Amano K; Niizeki T; Nakano M; Kuromatsu R; Torimura T
    Clin J Gastroenterol; 2018 Feb; 11(1):69-74. PubMed ID: 29082453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of antiviral therapy for chronic hepatitis C.
    Lemon SM
    Adv Exp Med Biol; 1999; 458():29-37. PubMed ID: 10549377
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of interferon therapy in "non responder" patients with chronic hepatitis C.
    Poynard T; Moussali J; Ratziu V; Regimbeau C; Opolon P
    J Hepatol; 1999; 31 Suppl 1():178-83. PubMed ID: 10622583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.
    Almasio PL; Venezia G; Craxì A
    Panminerva Med; 2003 Sep; 45(3):175-82. PubMed ID: 14618115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.
    Kasahara A; Tanaka H; Okanoue T; Imai Y; Tsubouchi H; Yoshioka K; Kawata S; Tanaka E; Hino K; Hayashi K; Tamura S; Itoh Y; Kiyosawa K; Kakumu S; Okita K; Hayashi N
    J Viral Hepat; 2004 Mar; 11(2):148-56. PubMed ID: 14996350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy.
    Ito Y; Yamamoto N; Nakata R; Kato Y; Iori M; Sakai K; Takemura T; Tateishi R; Yoshida H; Kawabe T; Omata M
    World J Gastroenterol; 2005 Dec; 11(45):7218-21. PubMed ID: 16437676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.
    Veldt BJ; Heathcote EJ; Wedemeyer H; Reichen J; Hofmann WP; Zeuzem S; Manns MP; Hansen BE; Schalm SW; Janssen HL
    Ann Intern Med; 2007 Nov; 147(10):677-84. PubMed ID: 18025443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.
    Yoshida H; Shiratori Y; Moriyama M; Arakawa Y; Ide T; Sata M; Inoue O; Yano M; Tanaka M; Fujiyama S; Nishiguchi S; Kuroki T; Imazeki F; Yokosuka O; Kinoyama S; Yamada G; Omata M
    Ann Intern Med; 1999 Aug; 131(3):174-81. PubMed ID: 10428733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma incidentally detected at second hepatectomy for repeated colorectal liver metastasis in a patient with hepatitis C virus-related cirrhosis: a case report.
    Kobayashi A; Morioka D; Matsumoto C; Miura Y; Miura M
    J Med Case Rep; 2016 May; 10(1):136. PubMed ID: 27234582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.